Literature DB >> 29866235

Dyke-Davidoff-Masson Syndrome: An Unusual Cause of Status Epilepticus and Refractory Seizures.

Mehtab Alam1, Mian Ayaz Ul Haq1, Fawad Ali1, Hina Mehwish2, Kalsoom Nawab3.   

Abstract

Dyke-Davidoff-Masson Syndrome (DDMS) is a rare neurological condition characterised by drug-resistance seizures, hemiparesis, mental retardation, facial asymmetry, and intellectual disabilities. On brain imaging, the disease is characterised by cerebral hemiatrophy with ipsilateral calvarial thickening and hyperpneumotisation of paranasal sinuses or mastoid air cells. Although more common in men and on the left side of the brain, the disease can affect both genders and cerebral hemispheres. It mainly presents in childhood. The adult presentation is unusual but has been reported in medical literature. Most of the patients need more than one antiepileptic agent for optimal control of seizures. Hemispherectomy is reserved for patients who have drug-resistant and disabling seizures. The good prognostic factors are disease onset before age of two and better seizure control. We report two cases of DDMS occurring in teenage boys who presented with status epilepticus. The clinical histories, radiological findings, and treatment of both patients are discussed below.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29866235     DOI: 10.29271/jcpsp.2018.06.S99

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  2 in total

1.  An unusual case of Dyke-Davidoff-Masson syndrome revealed by status epilepticus in a Malian patient.

Authors:  Samba O Djimdé; Abdoulaye Yalcouyé; Abdou Koïta; Hassana Samir; Pofinet Kebkiba; Chrystelle Awovi Gueli; Alassane B Maïga; Adama S Sissoko; Guida Landouré
Journal:  Clin Case Rep       Date:  2022-10-17

2.  Case Report and Literature Review: COVID-19 and status epilepticus in Dyke-Davidoff-Masson syndrome.

Authors:  Lourdes de Fátima Ibañez Valdés; Jerry Geroge; Sibi Joseph; Mohamed Alshmandi; Wendy Makaleni; Humberto Foyaca Sibat
Journal:  F1000Res       Date:  2021-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.